Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Medicare Advantage Part C clipboard payment

CMS drops lawsuit against UnitedHealth over Medicare Advantage star rating

The Centers for Medicare & Medicaid Services appealed a court ruling that ordered the agency to change the star rating for UnitedHealthcare's Medicare Part D plans, which had been reduced due to a disputed phone call. CMS has now dropped the appeal.

value quality value-based care

MGMA's perspective on CMS’s 2030 shift to value-based care

Anders Gilberg, Senior Vice of Government Affairs at Medical Group Management Association, explains the issues that will complicate moving Medicare from fee-for-service to value-based care models in five years.

 

artificial intelligence AI healthcare

Nat’l Academy of Medicine sets ‘priorities for action’ as healthcare mulls next moves with AI

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

MGMA's Anders Gilberg calls on CMS and Congress to extend telemedicine and highlights the issues involved.

Congress hesitates on long-term telemedicine expansion admid advocacy push

Congress temporarily extended telemedicine provisions until March amid lobby efforts by the Medical Group Management Association (MGMA) and others to make the provisions permanent.

Thumbnail

FDA warns of risk of death associated with multiple sclerosis drugs

The agency found 82 cases of anaphylaxis associated with glatiramer acetate, sold under the brand names Copaxone and Glatopa, including 19 that emerged after patients had been taking these drugs for more than a year.

Thumbnail

Trump administration halts public communications from health agencies

The indefinite hold on external communications includes website updates and social media posts, in addition to scientific reports, from all agencies under HHS. 

Donald J. Trump 2024

Trump signs executive order to withdraw U.S. from the World Health Organization

The President made good on a campaign promise to leave the international health agency, after attempting to do so when he last held office in 2020. 

Vintage neon drug sign at the Walgreens pharmacy on Canal Street in downtown New Orleans.

DOJ sues Walgreens for allegedly filling ‘millions’ of illegal prescriptions

Walgreens filed a countersuit, accusing the federal government of failing to take down prescribers acting unlawfully. 

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.